Global Health Research Seminar: Evaluation of Novartis Access in Kenya

Starts:
1:00 pm on Monday, March 27, 2017
Ends:
2:00 pm on Monday, March 27, 2017
Location:
CT-305
URL:
http://www.bu.edu/sph/about/departments/global-health/global-health-events/global-health-research-seminar-series/
Evaluation of Novartis Access in Kenya - Updates from Baseline and Surveillance Novartis Access BU Global Health Team (Richard Laing, Veronika Wirtz, Peter Rockers Paul Ashigbie, Taryn Vian, Monica Onyango) In 2016, Novartis launched Novartis Access, a corporate-responsibility program involving the direct sale of low-cost non-communicable disease medicines to public sector and not-for-profit purchasers in Kenya. Boston University researchers are evaluating the impact of Novartis Access on the availability and price of NCD medicines at facility and household levels. This presentation will review preliminary findings from baseline data collection and surveillance monitoring.